Article Information
- Received March 29, 2002
- Revision received August 9, 2002
- Accepted August 16, 2002
- First published November 1, 2002.
- Version of record published November 1, 2002.
Author Information
- Raquel Gómez1,
- Miguel Navarro1,
- Belén Ferrer2,
- José M. Trigo1,
- Ainhoa Bilbao2,
- Ignacio Del Arco2,
- Andrea Cippitelli2,
- Felice Nava3,
- Daniele Piomelli3, and
- Fernando Rodrı́guez de Fonseca2
- 1University Institute of Drug Dependencies, Department of Psychobiology, University Complutense of Madrid, Madrid 28223, Spain,
- 2Fundación de Investigación Carlos Haya, Hospital Universitario Carlos Haya, Málaga 29010, Spain, and
- 3Department of Pharmacology, University of California, Irvine, California 92697-4625
Author contributions
Disclosures
- Received March 29, 2002.
- Revision received August 9, 2002.
- Accepted August 16, 2002.
This work was supported by Fundación Rodrı́guez Pascual; Ministerio de Ciencia y Tecnologı́a, Fondo de Investigación Sanitaria 2002/0001; Plan Nacional Sobre Drogas and Del Amo Program–Universidad Complutense de Madrid (M.N. and F.R.F.); and by the National Institute on Drug Abuse (D.P.). We thank Dr. M. Mossé (Sanofi Research) for generously providing SR141716A.
Correspondence should be addressed to either of the following: Fernando Rodrı́guez de Fonseca, Hospital Carlos Hay Foundation, Carlos Haya Avenue 82, Seventh floor, Pavillion A, 29010 Málága, Spain, E-mail: frfonseca{at}hch.sas.junta-andalucia.es; or Miguel Navarro, Department of Psychobiology, Faculty of Psychology, Complutense University, 28040 Madrid, Spain, E-mail: mnavarro{at}psi.ucm.es.
